GlassScriptPhysician profile
Kunjali Tushar Padhya
NPI 1982867560
$6,328.32
in general payments reported to CMS, 2019-2025
15 companies · $4,123 in 2025
The $4,123 reported for 2025 was more than what 90% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.31 · 2020: $123 · 2021: $37.40 · 2022: $256 · 2023: $907 · 2024: $848 · 2025: $4,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,141 · Food and Beverage: $2,737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,141.00 |
| Food and Beverage | $2,737.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $3,250.81 | 2024-2025 | Dupixent |
| Boston Scientific Corporation | $1,305.38 | 2019-2025 | Exalt Model D, Apollo Esg Nxt System, Spyglass |
| Genzyme Corporation | $365.97 | 2023-2025 | |
| 3-D Matrix, INC. | $214.95 | 2024 | |
| Enterra Medical, INC. | $167.11 | 2023 | |
| Abbvie INC. | $162.48 | 2019-2025 | |
| Lilly USA, LLC | $125.00 | 2025 | Jardiance |
| Phathom Pharmaceuticals, INC. | $125.00 | 2025 | Voquezna |
| Aimmune Therapeutics, INC. | $122.71 | 2025 | Zenpep |
| Olympus America INC. | $116.36 | 2024 | Endoclot Phs |
| Takeda Pharmaceuticals U.S.A., INC. | $112.16 | 2023 | Entyvio |
| Erbe USA INC | $83.00 | 2024-2025 | Vio3 |
| Gilead Sciences, INC. | $67.02 | 2023 | |
| Cook Medical LLC | $64.07 | 2025 | Echotip Insight |
| Omega Medical Imaging, LLC | $46.30 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunjali Padhya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.